IP Verse

Dr Schn patent opposition analysis

The comprehensive analysis of Dr Schn opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Dr Schn

Stay updated with the latest patent oppositions filed by Dr Schn

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3411021
New Use Of A Combination Of Sacubitril And ValsartanNOVARTIS AGFeb 12, 2026DR SCHN
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AGJan 29, 2026DR SCHN
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORION CORPORATIONJan 9, 2026DR SCHN
EP3470400
Crystal Form Of Ozanimod, Crystal Form Of Hydrochloride Thereof, And Preparation Method ThereforRECEPTOS LLCDec 23, 2025DR SCHN
EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS AGJul 16, 2025DR SCHN
EP4125903
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICAL CO., LTD.Jul 1, 2025DR SCHN
EP4097091
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIES LTD.Jun 17, 2025DR SCHN
EP4041186
An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of PsoriasisLEO PHARMA A/SFeb 17, 2025DR SCHN
EP3373972
Compositions For Treating Spinal Muscular AtrophyF. HOFFMANN-LA ROCHE AGDec 20, 2024DR SCHN
EP3820625
Device For Dispensing A Fluid Product, And Method For Filling And For Plugging SameAPTAR FRANCE SASDec 12, 2024DR SCHN

Top clients of Dr Schn

Top companies who are the clients of Dr Schn

CompanyTotal
DR SCHN16